Telomere length is an independent prognostic marker in MDS but not inde novoAML-Reference-Cited by-同舟云学术

Telomere length is an independent prognostic marker in MDS but not inde novoAML

Published:2017-05-09 Issue:2 Volume:178 Page:240-249
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Williams Jenna¹,Heppel Nicole H.¹,Britt-Compton Bethan¹,Grimstead Julia W.¹,Jones Rhiannon E.¹,Tauro Sudhir²,Bowen David T.³,Knapper Steven¹,Groves Michael²,Hills Robert K.¹,Pepper Chris¹,Baird Duncan M.¹^ORCID,Fegan Chris¹^ORCID

Affiliation:

1. Division of Cancer and Genetics; School of Medicine; Cardiff University; Cardiff UK

2. Department of Haematology; Ninewells Hospital; Dundee UK

3. Department of Haematology; St James's Institute of Oncology; Leeds UK

Funder

Cancer Research UK

Bloodwise

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14666/fullpdf

Reference43 articles.

1. Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia;Aalbers;Leukemia,2013

2. Extensive allelic variation and ultrashort telomeres in senescent human cells;Baird;Nature Genetics,2003

3. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders;Ballew;Expert Review of Hematology,2013

4. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;The New England Journal of Medicine,2011

5. Telomere length in myelodysplastic syndromes;Boultwood;American Journal of Hematology,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic landscape of TP53-mutated myeloid malignancies;Blood Advances;2023-08-11

2. Predicted leukocyte telomere length and risk of myeloid neoplasms;Human Molecular Genetics;2023-08-02

3. Telomere integrated scoring system of myelodysplastic syndrome;Journal of Clinical Laboratory Analysis;2023-01-19

4. Genomic landscape ofTP53-mutated myeloid malignancies;2023-01-11

5. Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome;Journal of Clinical Medicine;2022-08-07